Exploring the Mechanism of tiRNA-Val-CAC-002 in the Pathogenesis of Oral Submucous Fibrosis.

Objectives: Oral submucous fibrosis (OSF) is a chronic, progressive, and potentially malignant disease of the oral cavity. A previous study by our team found that the aberrant expression of tRNA-derived small RNA (tsRNA) was involved in the development of OSF, with tiRNA-Val-CAC-002 showing the most significant difference. This study aimed to investigate the effect of tiRNA-Val-CAC-002 on fibroblast activation and its underlying mechanisms, elucidate the pathogenesis of OSF, and explore new effective targets for OSF prevention and treatment.

Expression profiles of tRNA-derived small RNA and their potential roles in oral submucous fibrosis.

Background: Although transfer RNA (tRNA) has been found to be the main source of a rich class of noncoding RNA, the tRNA-derived small RNA (tsRNA) has been proved to play an irreplaceable role in the human body, and its dynamic imbalance could affect the progress of the disease. However, the research on tsRNA in oral submucous fibrosis (OSF) is still scarce.

Methods: We sequenced the OSF and validated it by PCR.

Role of autophagy induced by arecoline in angiogenesis of oral submucous fibrosis.

Objectives: To detect the expression of protein light chain 3 (LC3) and p62-SQSTM1 (p62) in the lamina propria of oral submucous fibrosis (OSF) and to determine the association of autophagy with OSF. To investigate the role of autophagy in angiogenesis of human umbilical vein endothelial cells (HUVECs) and to assess whether this effect was induced by arecoline.

Methods: LC3 and p62 expression was detected in OSF tissue through immunohistochemistry (IHC).